1. P.015 Monthly migraine days, acute medication use-days, and migraine-specific quality of life in responders to atogepant: a post hoc analysis. (June 2022) Authors: Dodick, DW; Lipton, RB; Nahas, SJ; Pozo-Rosich, P; McAllister, P; Mechtler, LL; Leroux, E; Ma, J; Dabruzzo, B; Dufek, M; Severt, L; Finnegan, M; Trugman, J Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗